Navigating the complexities of clinical trial supply chains is more challenging than ever as the industry adapts to new technologies and ever-changing global regulations. On September 17, Eikon Therapeutics’ Senior Director of Clinical Supply Chain Reid Tonik will share insights on “Creating a Clinical Supply Chain Playbook for Onboarding Acquired Assets” at Clinical Trial Supply West Coast in San Francisco. Reid will cover best practices and actionable strategies including: ? Identifying priorities and guiding transition activities while mitigating risks to patient dosing and trial continuity in a culturally and personally mindful way. ? Deciding when and what to integrate, and assessing the impact on the acquired portfolio. ? Tools of the trade and lessons learned from past mistakes. We hope to see you there! ? #TeamEikon #ClinicalTrials?#ClinicalOperations #CTSWestCoast
Eikon Therapeutics的动态
最相关的动态
-
Mid-study changes in complex clinical trials are common. That’s why Endpoint’s #IRT offers configurable components for quick adjustments and flexibility, ensuring you can easily adapt to meet your trial needs. Your trials, and your team, will benefit from: --streamlined complex trial randomization methods. --improved drug supply management. --simplified site, study, and subject management. Learn more about Endpoint's #RTSM solutions today! https://ow.ly/FfJY50Q8thE
-
-
[CASE STUDY] Learn the full story of how we helped a #pharma company secure a global partnership for their pre-clinical asset in the #CNS space. ?? As this example shows, you can still maintain the rights in your region while also expanding to lucrative global markets. Download the full case study: https://buff.ly/3JHLiLh #partnering #pharmapartnering #businessdevelopment
-
Temperature Monitoring Expert @ Berlinger & Co. AG - Condition Monitoring Solutions
Looking for a seamless solution to streamline your clinical supply chain? Have a look below. I‘ll be happy to answer any questions you may have. #pharmaceuticalindustry #biotech #biopharma #patientsafety #temperaturemonitoring
Partner Spotlight: Berlinger and IQVIA – Elevating Clinical Trials with Enhanced Monitoring and Data Integrity ?? By integrating Berlinger’s state-of-the-art monitoring solutions with IQVIA’s innovative IRT, we are setting a new standard for clinical trial efficiency and data availability. Our commitment to advancing the clinical research landscape ensures that trial data is not only secure but also seamlessly accessible in real-time, empowering research teams to make informed decisions faster. ?? Learn more about this partnership: https://lnkd.in/eeNsDESK Together, let us transform the future of clinical trials! #Partnership #ClinicalTrials #DataIntegrity #SupplyChainMonitoring #Pharma #HealthcareInnovation #Berlinger #IQVIA #ClinicalResearch
-
-
What a whirlwind week for the LS team at the PCMG Clinical Outsourcing Community Annual Assembly!?We're excited to share the wealth of knowledge we gained focused on advancing the industry. Watch this video for Rob Aitchison's top takeaways! From molecule to medicine, 4C partners with the most innovative biopharma advisors and providers to face these challenges and support the global life sciences industry’s mission to achieve greater wellbeing for patients, consumers and society in its widest sense. Learn more here: https://lnkd.in/eCwDuSxX Will Sillar #PCMGAssembly #takeaways #Pharma #IndustryInsights
-
Professional Healthcare leader| Senior level Leadership skills | Experience supporting pharmaceutical trials | Project management skills | Detailed-oriented | Self-motivating | Collaboration skills
Learn about LabConnect services.
LabConnect offers innovative central laboratory?services and?functional service provider solutions?that are designed to?meet the unique needs of?traditional to?complex clinical trials. Explore our general capabilities overview: = >??https://bit.ly/3OEo1ey Learn how?we?can partner together to accelerate?the development of new?medicines. = >?https://bit.ly/3J08ggx #LabConnect?#ClinicalTrails?#CentralLab
-
The market research firm PitchBook reports private equity-backed healthcare deals have continued to decline, dropping 16.5% in the second quarter of this year. The market has been on a downward trend since 2021, but may be poised for a turnaround according to Healthcare Dive. "Bankers have noted their acquisition pipelines are filling up, and sellers’ price expectations are beginning to decrease — signaling that a gradual increase in dealmaking could be coming," writes reporter Emily Olsen. PitchBook's Healthcare Services Report claims that the acceleration in private equity deals will likely be focused on pharmaceutical services, healthcare information technology and other non-physician practice management firms. You can read full coverage of the report at: https://lnkd.in/e3GZWNwx #HealthcareDeals #PitchBook #PrivateEquityTrends
-
-
A staggering 80% of clinical drug trials face delays, posing significant challenges to budgets and delivery timelines. With daily costs running between $600,000 to $8 million, even a short delay can have substantial financial repercussions. Find out how strategic planning and the right partnerships can help mitigate these delays in our comprehensive guide. ?? Learn more in our latest blog: https://lnkd.in/gHNDbdsX #ClinicalTrialDelays #DrugTrialCosts #PharmaIndustry #ClinicalResearch #TrialManagement
-
-
We are proud to announce Boomerang Biopathways. Please see the press release launching the firm! Boomerang Biopathways Pty Ltd is a leading provider of early clinical trial services, specializing in helping BioPharma and MedTech companies conduct clinical trials in Australia. Our mission is to accelerate clinical outcomes by leveraging Australia’s unique advantages—speed, cost-efficiency, and high-quality data. From legal setup to full trial execution, we offer comprehensive support, enabling companies to bring innovative therapies to market faster while enhancing value creation. With a team of seasoned experts and a focus on seamless trial management, Boomerang Biopathways is the trusted partner for global companies seeking to optimize their clinical development programs in Australia. Karen S. Steven Suchting Matthew White, CFA Dr Grace Ng Dr Chris Booth #ClinicalTrials #BioPharma #BioTech #MedTech #RDTaxIncentive #RDTI #ClinicalResearch #DrugDevelopment #MedicalDevices #Australia #Phase1 #Australia #FDAApprovedTrials #
-
#LabConnect?#ClinicalTrails?#CentralLab LabConnect offers innovative central laboratory?services and?functional service provider solutions?that are designed to?meet the unique needs of?traditional to?complex clinical trials. Explore our general capabilities overview: ?? https://bit.ly/3OEo1ey Learn how?we?can partner together to accelerate?the development of new?medicines. = >?https://bit.ly/3J08ggx
LabConnect offers innovative central laboratory?services and?functional service provider solutions?that are designed to?meet the unique needs of?traditional to?complex clinical trials. Explore our general capabilities overview: = >??https://bit.ly/3OEo1ey Learn how?we?can partner together to accelerate?the development of new?medicines. = >?https://bit.ly/3J08ggx #LabConnect?#ClinicalTrails?#CentralLab
-
Director of Business Development - Central Lab Services | FSP | Consulting | EMEA | Located in UK
Planning your next clinical trial and would like to learn more about how LabConnect can support you?
LabConnect offers innovative central laboratory?services and?functional service provider solutions?that are designed to?meet the unique needs of?traditional to?complex clinical trials. Explore our general capabilities overview: = >??https://bit.ly/3OEo1ey Learn how?we?can partner together to accelerate?the development of new?medicines. = >?https://bit.ly/3J08ggx #LabConnect?#ClinicalTrails?#CentralLab
